ORIENT BIO Inc. (KRX:002630)
South Korea flag South Korea · Delayed Price · Currency is KRW
840.00
-33.00 (-3.78%)
Sep 1, 2026, 3:30 PM KST

ORIENT BIO Cash Flow Statement

Millions KRW. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
TTMFY 2021FY 2020FY 2019FY 2018FY 2017
Period Ending
Dec '21 Mar '21 Mar '20 Mar '19 Mar '18 Mar '17
Net Income
-6,853-15,634-11,996-19,506-13,865-19,582
Depreciation & Amortization
4,2104,6914,9188,0787,2966,665
Other Amortization
--45.993,0273,371646.52
Loss (Gain) From Sale of Assets
-40.86-2.27-5.54-7.34-57.95-610.9
Asset Writedown & Restructuring Costs
5,0335,0642,2752,0942,7266,591
Loss (Gain) From Sale of Investments
34.44-36.96-1.5201
Loss (Gain) on Equity Investments
3,2043,601-849.66---
Provision & Write-off of Bad Debts
1,9931,414-493.11-1,166-78.55-40.77
Other Operating Activities
1,1419,211893.3-8,698-3,239-4,660
Change in Accounts Receivable
-3,461869.29-2,381-3,982-2,698478.16
Change in Inventory
-576.582,1752,1797,223-2,4083,870
Change in Accounts Payable
208.9749.33-2743,6591,038-818.32
Change in Income Taxes
----13.2413.39
Change in Other Net Operating Assets
6,845-2,6991,747-2,2615,934113.98
Operating Cash Flow
11,7378,739-3,904-11,540-1,966-5,108
Operating Cash Flow Growth
1841.66%-----

Investing Activities

Fiscal Year
TTMFY 2021FY 2020FY 2019FY 2018FY 2017
Period Ending
Dec '21 Mar '21 Mar '20 Mar '19 Mar '18 Mar '17
Capital Expenditures
-2,407-256.16-742.94-16,080-2,987-5,283
Sale of Property, Plant & Equipment
107.342.275.554,689137.913,764
Cash Acquisitions
----5,692-11,258-
Sale (Purchase) of Intangibles
--1,087-2,350-259.75-1,347
Investment in Securities
845.56-1194,865-190.28-10,293-138.79
Other Investing Activities
-1,688-1,492-72.5-1,353-278.83-26.15
Investing Cash Flow
-4,103-4,033-347.26-26,732-26,524-5,100

Financing Activities

Fiscal Year
TTMFY 2021FY 2020FY 2019FY 2018FY 2017
Period Ending
Dec '21 Mar '21 Mar '20 Mar '19 Mar '18 Mar '17
Short-Term Debt Issued
--5002,8962,30015,224
Long-Term Debt Issued
---7,19249,71314,896
Total Debt Issued
522.8-50010,08752,01330,120
Short-Term Debt Repaid
---1,860--3,953-23,316
Long-Term Debt Repaid
--1,074-1,218-50,484-15,206-6,580
Total Debt Repaid
-2,696-1,074-3,078-50,484-19,160-29,896
Net Debt Issued (Repaid)
-2,173-1,074-2,578-40,39732,854223.72
Issuance of Common Stock
19.764,949-32,8379.58-
Repurchase of Common Stock
---10.02---
Other Financing Activities
--4.530,5641,05520,555
Financing Cash Flow
-2,1543,875-2,58423,00433,91920,779

Net Cash Flow

Fiscal Year
TTMFY 2021FY 2020FY 2019FY 2018FY 2017
Period Ending
Dec '21 Mar '21 Mar '20 Mar '19 Mar '18 Mar '17
Foreign Exchange Rate Adjustments
459.818.9815.35---
Miscellaneous Cash Flow Adjustments
0----0-0
Net Cash Flow
5,9408,590-6,820-15,2685,42810,571

Free Cash Flow

Fiscal Year
TTMFY 2021FY 2020FY 2019FY 2018FY 2017
Period Ending
Dec '21 Mar '21 Mar '20 Mar '19 Mar '18 Mar '17
Free Cash Flow
9,3308,483-4,647-27,620-4,953-10,391
Free Cash Flow Growth
4259.59%-----
Free Cash Flow Margin
15.79%16.31%-12.49%-90.94%-19.33%-9.53%
Free Cash Flow Per Share
157.40149.85-90.05-709.07-137.95-295.47
Levered Free Cash Flow
-1,3555,053-1,752-9,19122,551-6,231
Unlevered Free Cash Flow
-1,0065,403-1,383-10,06719,180-5,108

Additional Metrics

Fiscal Year
TTMFY 2021FY 2020FY 2019FY 2018FY 2017
Period Ending
Dec '21 Mar '21 Mar '20 Mar '19 Mar '18 Mar '17
Cash Interest Paid
325.75315.2937.44812.875,3423,616
Cash Income Tax Paid
21.42--93.7113.2413.3947.61
Change in Working Capital
3,016394.341,2714,6391,8795,682